Rezira

Rezira is a brand name of hydrocodone/pseudoephedrine, approved by the FDA in the following formulation(s):

REZIRA (hydrocodone bitartrate; pseudoephedrine hydrochloride - solution; oral)

• 
  Manufacturer: CYPRESS PHARM
  
  Approval date: June 8, 2011
  
  Strength(s): 5MG/5ML;60MG/5ML ^[RLD]

Has a generic version of Rezira been approved?

No. There is currently no therapeutically equivalent version of Rezira available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rezira. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Rezira.

See also...

• Rezira Consumer Information (Drugs.com)
• Rezira Advanced Consumer Information (Micromedex)
• Hydrocodone/Pseudoephedrine Consumer Information (Wolters Kluwer)
• Hydrocodone/Pseudoephedrine Liquid Consumer Information (Wolters Kluwer)
• Hydrocodone and pseudoephedrine Advanced Consumer Information (Micromedex)